We are live on ! Find out more
DM

Deerfield Management Portfolio holdings

AUM $8.48B
1-Year Est. Return 99.04%
This Fund
S&P 500
This Quarter Est. Return
-8.37%
1 Year Est. Return
+99.04%
3 Year Est. Return
+273.78%
5 Year Est. Return
+280.99%
10 Year Est. Return
+2,168.14%
AUM
$5.28B
AUM Growth
-$1.41B
Cap. Flow
-$1.19B
Cap. Flow %
-22.61%
Top 10 Hldgs %
53.54%
Holding
466
New
23
Increased
24
Reduced
24
Closed
360

Top Buys

Rank Stock Value
1
NAMS icon
NewAmsterdam Pharma
NAMS
+$72.5M
2
LEGN icon
Legend Biotech
LEGN
+$64.3M
3
OSCR icon
Oscar Health
OSCR
+$64.1M
4
DVAX
Dynavax Technologies
DVAX
+$62.6M
5
INDV icon
Indivior Pharmaceuticals
INDV
+$39M

Top Sells

Rank Stock Value
1
NUVL
Nuvalent
NUVL
+$187M
2
KURA icon
Kura Oncology
KURA
+$106M
3
CPRX
Catalyst Pharmaceutical
CPRX
+$66.5M
4
SGRY icon
Surgery Partners
SGRY
+$57.4M
5
NBIX icon
Neurocrine Biosciences
NBIX
+$56.2M

Sector Composition

Rank Sector Weight
1 Healthcare 87.97%
2 Industrials 0.23%
3 Consumer Staples 0.01%
4 Energy 0%
5 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FTRE icon
226
Fortrea Holdings
FTRE
$1.91B
– –
-105,470
Closed -$2.11M
TDAY
227
USA Today Co
TDAY
$1.3B
– –
-27,331
Closed -$154K
GHC icon
228
Graham Holdings Company
GHC
$5.33B
– –
-617
Closed -$507K
GKOS icon
229
Glaukos
GKOS
$9.21B
– –
-1,938
Closed -$252K
GL icon
230
Globe Life
GL
$13.9B
– –
-2,057
Closed -$218K
GPN icon
231
Global Payments
GPN
$24B
– –
-9,580
Closed -$981K
GRC icon
232
Gorman-Rupp
GRC
$2.09B
– –
-24,253
Closed -$945K
GS icon
233
Goldman Sachs
GS
$294B
– –
-808
Closed -$400K
GTLS
234
DELISTED
Chart Industries
GTLS
– –
-3,130
Closed -$389K
HCKT icon
235
Hackett Group
HCKT
$275M
– –
-39,550
Closed -$1.04M
HCSG icon
236
Healthcare Services Group
HCSG
$1.59B
– –
-66,786
Closed -$746K
HLIO icon
237
Helios Technologies
HLIO
$2.51B
– –
-19,995
Closed -$954K
HNRG icon
238
Hallador Energy
HNRG
$657M
– –
-112,711
Closed -$1.06M
HOPE icon
239
Hope Bancorp
HOPE
$1.8B
– –
-25,959
Closed -$326K
HPE icon
240
Hewlett Packard
HPE
$59.9B
– –
-15,583
Closed -$319K
HQY icon
241
HealthEquity
HQY
$8.68B
– –
-11,781
Closed -$964K
HROW icon
242
Harrow
HROW
$1.46B
– –
-13,863
Closed -$623K
HRZN icon
243
Horizon Technology Finance
HRZN
$294M
– –
-64,708
Closed -$689K
HUBG icon
244
HUB Group
HUBG
$2.9B
– –
-15,555
Closed -$707K
PPLI
245
People Inc
PPLI
$3.15B
– –
-11,526
Closed -$509K
IDXX icon
246
Idexx Laboratories
IDXX
$44.9B
– –
-2,643
Closed -$1.34M
IEX icon
247
IDEX
IEX
$17.2B
– –
-7,106
Closed -$1.52M
IMO icon
248
Imperial Oil
IMO
$62.1B
– –
-4,027
Closed -$284K
INGR icon
249
Ingredion
INGR
$6.45B
– –
-2,598
Closed -$357K
INO icon
250
Inovio Pharmaceuticals
INO
$83.9M
– –
-76,523
Closed -$442K
8 9
10
11 12

Similar funds

FT
Fiduciary Trust Boston, Massachusetts $8.46B AUM 21.38% 1-Year Est. Return
GRQ
Gardner Russo & Quinn Lancaster, Pennsylvania $8.5B AUM 9.79% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
VA
Valmark Advisers Akron, Ohio $8.42B AUM 14.36% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $8.4B AUM 63.34% 1-Year Est. Return
IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
NW
NewEdge Wealth Pittsburgh, Pennsylvania $8.39B AUM 24.47% 1-Year Est. Return
AAF
Andra AP-fonden Goteborg, Sweden $8.39B AUM 21.19% 1-Year Est. Return

Deerfield Management's Q4 2024 Portfolio in Review

As of Q4 2024, Deerfield Management held 466 positions worth $5.28B, down 21% from $6.69B the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Deerfield Management withdrew a net $1.19B in Q4 2024, closing 360 positions and reducing 24 holdings. Its most notable exit was Kura Oncology, an estimated $106M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 88% of assets, up from 87% a quarter earlier, followed by Industrials and Consumer Staples.

Against the trend, Deerfield Management opened a new position in Legend Biotech worth $50.5M.

  • Deerfield Management's largest Q4 2024 buy was Legend Biotech: 1,551,718 shares worth $50.5M.
  • Deerfield Management added most to NewAmsterdam Pharma in Q4 2024, an estimated $72.5M increase.
  • Deerfield Management's biggest Q4 2024 reduction was Nuvalent, cutting an estimated $187M.
  • Deerfield Management fully exited Kura Oncology in Q4 2024, selling an estimated $106M.
  • Deerfield Management's ten largest holdings make up 54% of its $5.28B portfolio in Q4 2024.
  • Deerfield Management opened 23 new positions and closed 360 in Q4 2024.
  • Deerfield Management's portfolio value fell 21% quarter-over-quarter to $5.28B.

Based on Deerfield Management's 13F filing for Q4 2024, filed 14 Feb 2025.